Yale Medicine’s Prostate & Genitourinary Radiotherapy program is at the forefront of cutting-edge cancer care. Offering ultrasound-guided transperineal prostate brachytherapy, image-guided Intensity Modulated Radiation Therapy (IMRT), and Calypso radiofrequency beacon-guided IMRT, our program provides nationally recognized and evidence-based radiotherapy treatment in a caring and personalized environment.

Together with our proven and widely published experience in prostate radiotherapy and our research into the comparative effectiveness of new radiation technologies for prostate cancer, we are a national and international leader in the field. Using the most sophisticated techniques, we continually develop new guidelines and insights in the use of radiation for prostate cancer.